Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Microbial flora balance" refers to the optimal state of equilibrium among the microbial populations, mainly bacteria, colonizing a specific site—most notably the human gut. This state of eubiosis is crucial for digestion, metabolism, immune regulation, and pathogen resistance. Disruptions (dysbiosis) have been linked to a range of local and systemic diseases, including inflammatory and infectious diseases, metabolic syndrome, allergies, and neurodegenerative conditions. Interventions to restore microbial balance include probiotics, prebiotics, fecal microbiota transplantation, antibiotics (to reduce select pathogens), and dietary modification. The concept is a systems-level property rather than a druggable molecular entity.
Restoration of microbial diversity (e.g., FMT); Modulation of metabolite production (via probiotics/prebiotics); Pathogen suppression (via competitive exclusion and antimicrobial peptide production); Immune response modulation (via changes in microbial metabolites and antigen stimulation)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial flora balance.